Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Keyrock Strengthens Position with $1.1 Billion Valuation

Crypto investment specialist Keyrock secures significant market valuation boost.Highlights: Keyrock achieves a $1.1 billion valuation.Funding round aims to...

LSEG Partners with Dell to Build Private Cloud Platform

Collaboration aims to enhance LSEG's cloud capabilities for financial services.Highlights: LSEG partners with Dell to create a private...

Ethical Savings App Zero Ceases Trading Amid Financial Challenges

Zero, known for promoting ethical savings, halts operations due to financial issues.Highlights: Ethical savings app Zero has ceased...

Wise Launches UK Current Account, Strengthening Banking Services

New offering aims to enhance financial management for UK customers.Highlights: Wise unveils its new current account service in...